C07D 277/38
Nitrogen atoms
C07D277/38 (Nitrogen atoms) appears on 1,803 US grants and 1,601 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,803
- Published applications
- 1,601
- Assignees
- 829
- Inventors
- 5,432
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 15 | 0 |
| 1978 | 28 | 0 |
| 1979 | 15 | 0 |
| 1980 | 24 | 0 |
| 1981 | 29 | 0 |
| 1982 | 24 | 0 |
| 1983 | 28 | 0 |
| 1984 | 26 | 0 |
| 1985 | 31 | 0 |
| 1986 | 25 | 0 |
| 1987 | 35 | 0 |
| 1988 | 25 | 0 |
| 1989 | 22 | 0 |
| 1990 | 23 | 0 |
| 1991 | 19 | 0 |
| 1992 | 22 | 0 |
| 1993 | 45 | 0 |
| 1994 | 26 | 0 |
| 1995 | 23 | 0 |
| 1996 | 33 | 0 |
| 1997 | 46 | 0 |
| 1998 | 25 | 0 |
| 1999 | 28 | 0 |
| 2000 | 24 | 0 |
| 2001 | 43 | 7 |
| 2002 | 30 | 44 |
| 2003 | 36 | 83 |
| 2004 | 39 | 101 |
| 2005 | 38 | 101 |
| 2006 | 42 | 90 |
| 2007 | 50 | 91 |
| 2008 | 53 | 90 |
| 2009 | 63 | 87 |
| 2010 | 66 | 102 |
| 2011 | 68 | 65 |
| 2012 | 71 | 63 |
| 2013 | 59 | 63 |
| 2014 | 71 | 60 |
| 2015 | 54 | 60 |
| 2016 | 47 | 48 |
| 2017 | 48 | 59 |
| 2018 | 35 | 53 |
| 2019 | 57 | 48 |
| 2020 | 30 | 43 |
| 2021 | 33 | 40 |
| 2022 | 30 | 45 |
| 2023 | 22 | 52 |
| 2024 | 25 | 52 |
| 2025 | 25 | 33 |
| 2026 | 17 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Compound having inhibitory activity against O-glusacase and use thereof28 Jul 2026US 12,692,260 B2Medifron DBT Co., Ltd.
- BAF complex modulating compounds21 Jul 2026US 12,685,735 B2Foghorn Therapeutics Inc.
- Substituted aminothiazoles as DGKzeta inhibitors for immune activation7 Jul 2026US 12,673,927 B2Deutsches Krebsforschungszentrum
- Neuroprotective compositions and methods of using the same23 Jun 2026US 12,661,340 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Hiv-1p rotease inhibitors and uses thereof17 Sep 2026US 2026/0272926 A1Purdue Research Foundation
- Cgas antagonist compounds17 Sep 2026US 2026/0274808 A1Board of Regents, The University of Texas System
- Thiazole compounds as dgk¿ inhibitors17 Sep 2026US 2026/0274847 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Antibacterial and synergistic active compound and use thereof27 Aug 2026US 2026/0250257 A1East China University of Science and Technology
- Usp2 inhibitors and methods of using the same for the treatment of diseases20 Aug 2026US 2026/0242394 A1Beth Israel Deaconess Medical Center, Inc.
Most cited
By later US patents
- Heterocyclic self-immolative linkers and conjugates164US 7,375,078 B2Genentech, Inc. · 2008
- Cephem derivative162US 4,278,793 AHoechst Aktiengesellschaft · 1981
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Glutaramide diuretic agents156US 5,030,654 APfizer Inc. · 1991
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008